T
Timothy J Wilt
Researcher at University of Minnesota
Publications - 479
Citations - 41016
Timothy J Wilt is an academic researcher from University of Minnesota. The author has contributed to research in topics: Prostate cancer & Randomized controlled trial. The author has an hindex of 94, co-authored 457 publications receiving 36650 citations. Previous affiliations of Timothy J Wilt include Cochrane Collaboration & Agency for Healthcare Research and Quality.
Papers
More filters
The Effects of Shared Decision Making on Cancer Screening – A Systematic Review
Sarah E. Lillie,Melissa R. Partin,Kathryn L. Rice,Angela E Fabbrini,Nancy Greer,Sagar S. Patel,Roderick MacDonald,Indulis Rutks,Timothy J Wilt +8 more
TL;DR: This work included studies involving adults in a clinic setting, either at or shortly before an appointment, as a component to encourage SDM with the clinician and excluded studies that encouraged screening.
Journal ArticleDOI
Interventions to Prevent or Delay Long-Term Nursing Home Placement for Adults With Impairments-a Systematic Review of Reviews
Wei Duan-Porter,Kristen Ullman,Christina E. Rosebush,Lauren McKenzie,Kristine E. Ensrud,Edward Ratner,Nancy Greer,Tetyana P Shippee,Joseph E. Gaugler,Timothy J Wilt +9 more
TL;DR: Evidence indicated no benefit or inconsistent effects of HCBS in preventing or delaying NHP, and demonstration of substantial impacts on NHP may require longer-term studies of higher-intensity interventions that can be adapted for a variety of settings.
Journal ArticleDOI
Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects.
TL;DR: BTX may improve UI for subjects with refractory DO and the preferred dose and type of BTX is not known, but long-term efficacy and safety remain unclear and require conduct of larger RCT using standardized and validated clinical outcomes measures.
Journal ArticleDOI
Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.
TL;DR: Observation plus SRT may be optimal for men likely to comply with surveillance who wish to minimize side effects of the treatment, and outcomes reflect outcomes for the average patient given the current level of evidence.